AGP Executive Report
Last update: 12 hours agoMars Exploration: China’s Tianwen-3 chief scientist says the mission’s top goal is finding signs of past life, with sample return targeted for about 2031 after a launch around 2028. Medical Science: A Phase 3 trial found AstraZeneca/Amgen’s Tezspire met key endpoints for eosinophilic esophagitis, and a Cambridge-led study reports low placental protein ISM2 could predict preeclampsia and fetal growth restriction. Biology & Health: Researchers mapped how SurA helps bacteria build antibiotic-resistant outer barriers, while new work links low-level GLP-1 use to slower biological aging signals. Space & Physics: Studies refine how supernovas make and spread titanium-44, and teams use AI to help CERN decide which collision data to keep. Tech & Society: Boston Scientific begins restoring shipping after a cyberattack, and the FDA recall flags fracture risk for unused spinal cord stimulator leads. Education: Minnesota MCA results show widespread science underperformance in multiple districts. Quirky Science: The 2026 Ig Nobels went to cockroach milk, nose-blowing, and other delightfully odd experiments.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.